Professor Sinthia Bosnic-Anticevich is internationally recognised as an expert in respiratory medicines use. She is founder and Head of the Quality Use of Respiratory Medicines Group at the Woolcock Institute of Medical Research and The University of Sydney. Sinthia’s research has led to the development of gold standards in the use of inhalers, impacting on national and international treatment guidelines for asthma, COPD and allergic rhinitis.  Sinthia has authored over 200 research publications and been awarded over $20m in research funding. She has a reputation for an innovative and pragmatic approach to solving health care problems associated with medicines use and is regularly invited to present both nationally and internationally to clinicians across a range of health disciplines on the topic of respiratory medicines use. 

Medical Researcher & Respiratory Pharmacist, The University of Sydney

PROFESSOR SINTHIA BOSNIC-ANTICEVICH

Session:

Alan Russell Oration: Global search for innovation
– learnings for Community Pharmacy in Australia

When:

Thursday 19 March, 12.15pm –1.00pm

Proudly sponsored by:

SESSION SPONSOR

PROGRAM SPONSOR

MAJOR SPONSOR

VIEW ALL

PRINCIPAL SPONSOR

APP2020 SPONSORS

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by:

SESSION SPONSORS

PROGRAM SPONSORS

MAJOR SPONSORS

PRINCIPAL SPONSORS

APP2022 SPONSORS

FOLLOW US

SPONSORSHIP & TRADE

(c) 2021 APP Conference 2022. All Rights Reserved.

LATEST NEWS

#APP2022

Events Division

The Pharmacy Guild of Australia

Queensland Branch

OFFICIAL EVENT PARTNER

07 3831 9246

SITE CREDITS

CONTACT US

APP Sand 1

AA8730

APP OCEAN 3

2F7A81

APP OCEAN 2

347D83

GOLD

D3A94A

TEAL 

4AB9B7